Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

01-12-2020 | Insulins | Case report

A case of acanthosis nigricans in a HIV-infected patient

Authors: Alessandra Iacovelli, Ivano Mezzaroma, Marcello Di Paolo, Giuseppe Soda, Ludovica De Vincentiis, Paolo Palange

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

To date, very little information is available concerning the relationship between acanthosis nigricans (AN) and infection with human immunodeficiency virus type 1 (HIV-1).

Case presentation

Herein, we report the case of a middle-aged man admitted for fever and progressively worsening dyspnea in the context of an opportunistic pneumonia and firstly diagnosed with acquired immunodeficiency syndrome (AIDS). At the time of diagnosis, physical examination revealed the presence of a palpable, hyperpigmented skin lesion on the left areola with surface desquamation and velvety texture consistent with AN. Of note, the most common primary etiologies related to AN were excluded and the complete regression of the skin lesion was observed once antiretroviral therapy was started.

Conclusion

This is the second report of AN found in patients with AIDS and apparently responsive to prolonged antiretroviral treatment. Possible explanations of this association are still not completely understood, probably related to virus-induced changes in lipid metabolism. Our experience suggests that HIV testing should always be considered in the setting of apparently idiopathic AN.
Literature
1.
go back to reference Karadağ S, Yo Y, Danarti R, Al-Khuzaei S, Chen W. Acanthosis nigricans and the metabolic syndrome. Clin Dermatol. 2018;36:48–53.CrossRef Karadağ S, Yo Y, Danarti R, Al-Khuzaei S, Chen W. Acanthosis nigricans and the metabolic syndrome. Clin Dermatol. 2018;36:48–53.CrossRef
2.
3.
go back to reference Maltez F, Martins T, Morgando A, Proenca R. Will Acanthosis nigricans be a new cutaneous manifestation of human immunodeficiency virus infection? Acta Medica Port. 1997;10:493–5. Maltez F, Martins T, Morgando A, Proenca R. Will Acanthosis nigricans be a new cutaneous manifestation of human immunodeficiency virus infection? Acta Medica Port. 1997;10:493–5.
4.
go back to reference Mellor-Pita S, Yebra-Bango M, Alfaro-Martínez J, Suárez E. Acanthosis nigricans: a new manifestation of insulin resistance in patients receiving treatment with protease inhibitors. Clin Infect Dis. 2002;34:716.CrossRef Mellor-Pita S, Yebra-Bango M, Alfaro-Martínez J, Suárez E. Acanthosis nigricans: a new manifestation of insulin resistance in patients receiving treatment with protease inhibitors. Clin Infect Dis. 2002;34:716.CrossRef
5.
go back to reference Stoddart ML, Blevins KS, Lee ET, Wang W, Blackett PR. Cherokee diabetes study. Association of acanthosis nigricans with hyperinsulinemia compared with other selected risk factors for type 2 diabetes in Cherokee Indians: the Cherokee diabetes study. Diabetes Care. 2002;25(6):1009–14.CrossRef Stoddart ML, Blevins KS, Lee ET, Wang W, Blackett PR. Cherokee diabetes study. Association of acanthosis nigricans with hyperinsulinemia compared with other selected risk factors for type 2 diabetes in Cherokee Indians: the Cherokee diabetes study. Diabetes Care. 2002;25(6):1009–14.CrossRef
6.
go back to reference Torley D, Bellus GA, Munro CS. Genes, growth factors and acanthosis nigricans. Br J Dermatol. 2002;147(6):1097–101. Torley D, Bellus GA, Munro CS. Genes, growth factors and acanthosis nigricans. Br J Dermatol. 2002;147(6):1097–101.
7.
go back to reference Duro M, Manso MC, Barreira S, Rebelo I, Medeiros R, Almeida C. Metabolic syndrome in human immunodeficiency virus-infected patients. Int J STD AIDS. 2018;29(11):1089–97.CrossRef Duro M, Manso MC, Barreira S, Rebelo I, Medeiros R, Almeida C. Metabolic syndrome in human immunodeficiency virus-infected patients. Int J STD AIDS. 2018;29(11):1089–97.CrossRef
8.
go back to reference Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996;271(5249):665–8.CrossRef Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996;271(5249):665–8.CrossRef
9.
go back to reference Reus S, Portilla J, Sánchez-Payá J, Giner L, Francés R, Such J, Boix V, Merino E, Gimeno A. Low-level HIV viremia is associated with microbial translocation and inflammation. J Acquir Immune Defic Syndr. 2013;62(2):129–34.CrossRef Reus S, Portilla J, Sánchez-Payá J, Giner L, Francés R, Such J, Boix V, Merino E, Gimeno A. Low-level HIV viremia is associated with microbial translocation and inflammation. J Acquir Immune Defic Syndr. 2013;62(2):129–34.CrossRef
10.
go back to reference Yudkin JS, Juhan-Vague I, Hawe E, et al. Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism. 2004;53:852–7.CrossRef Yudkin JS, Juhan-Vague I, Hawe E, et al. Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism. 2004;53:852–7.CrossRef
11.
go back to reference Baril L, Beucler I, Valantin MA, et al. Low lipolytic enzyme activity in patients with severe hypertriglyceridemia on highly active antiretroviral therapy. AIDS 2001; 15: 415–417. 14.CrossRef Baril L, Beucler I, Valantin MA, et al. Low lipolytic enzyme activity in patients with severe hypertriglyceridemia on highly active antiretroviral therapy. AIDS 2001; 15: 415–417. 14.CrossRef
12.
go back to reference Hellerstein MK, Grunfeld C, Wu K, et al. Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. J Clin Endocrinol Metab. 1993;76:559–65.PubMed Hellerstein MK, Grunfeld C, Wu K, et al. Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. J Clin Endocrinol Metab. 1993;76:559–65.PubMed
13.
go back to reference El-Sadr WM, Mullin CM, Carr A, Gibert C, Rappoport C, Visnegarwala F, Grunfeld C, Raghavan SS. Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort. HIV Medicine. 2005;6:114–21.CrossRef El-Sadr WM, Mullin CM, Carr A, Gibert C, Rappoport C, Visnegarwala F, Grunfeld C, Raghavan SS. Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort. HIV Medicine. 2005;6:114–21.CrossRef
14.
go back to reference Melchior JC. Metabolic aspects of HIV: associated wasting. Biomed Pharmacother. 1997;51(10):455–60.CrossRef Melchior JC. Metabolic aspects of HIV: associated wasting. Biomed Pharmacother. 1997;51(10):455–60.CrossRef
15.
go back to reference Schulte-Hermann K, Schalk H, Haider B, Hutterer J, Gmeinhart B, Pichler K, et al. Impaired lipid profile and insulin resistance in a cohort of Austrian HIV patients. J Infect Chemother. 2016;22(4):248–53.CrossRef Schulte-Hermann K, Schalk H, Haider B, Hutterer J, Gmeinhart B, Pichler K, et al. Impaired lipid profile and insulin resistance in a cohort of Austrian HIV patients. J Infect Chemother. 2016;22(4):248–53.CrossRef
16.
go back to reference Zaid D, Greenman Y. Human immunodeficiency virus infection and the endocrine system. Endocrinol Metab. 2019;34:95–105.CrossRef Zaid D, Greenman Y. Human immunodeficiency virus infection and the endocrine system. Endocrinol Metab. 2019;34:95–105.CrossRef
17.
go back to reference Pulakhandam U, Dincsoy HP. Cytomegaloviral adrenalitis and adrenal insufficiency in AIDS. Am J Clin Pathol. 1990;93(5):651–6.CrossRef Pulakhandam U, Dincsoy HP. Cytomegaloviral adrenalitis and adrenal insufficiency in AIDS. Am J Clin Pathol. 1990;93(5):651–6.CrossRef
Metadata
Title
A case of acanthosis nigricans in a HIV-infected patient
Authors
Alessandra Iacovelli
Ivano Mezzaroma
Marcello Di Paolo
Giuseppe Soda
Ludovica De Vincentiis
Paolo Palange
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05089-1

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue